Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oramed Pharmaceuticals (DE:OJU1)
FRANKFURT:OJU1
Holding DE:OJU1?
Track your performance easily
OJU1 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€1.89 - €3.26
Previous Close€2.29
Volume0.00
Average Volume (3M)629.00
Market Cap
€94.67M
Enterprise Value-€114.33K
Total Cash (Recent Filing)$99.56M
Total Debt (Recent Filing)$464.00K
Price to Earnings (P/E)―
Beta0.37
Next Earnings
Jul 10, 2024EPS Estimate
<€0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding40,312,069
10 Day Avg. Volume221
30 Day Avg. Volume629
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.59
Price to Sales (P/S)74.31
Price to Cash Flow (P/CF)-3.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-0.09
Enterprise Value/Ebitda-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oramed Pharm News
PremiumCompany Announcements
Oramed Pharmaceuticals Reinforces Scilex Financial Ties
PremiumCompany Announcements
Oramed Pharm Names Avraham Gabay as New CFO
PremiumCompany Announcements
Oramed Pharmaceuticals Seeks New CFO After ResignationOptions Prices
Currently, No data available
---
Ownership Overview
15.30% Insiders
0.10% Mutual Funds
11.53% Other Institutional Investors
72.53% Public Companies and
Individual Investors
OJU1 FAQ
What was Oramed Pharmaceuticals’s price range in the past 12 months?
Oramed Pharmaceuticals lowest stock price was €1.89 and its highest was €3.25 in the past 12 months.
What is Oramed Pharmaceuticals’s market cap?
Currently, no data Available
When is Oramed Pharmaceuticals’s upcoming earnings report date?
Oramed Pharmaceuticals’s upcoming earnings report date is Jul 10, 2024 which is 176 days ago.
How were Oramed Pharmaceuticals’s earnings last quarter?
Oramed Pharmaceuticals released its earnings results on Jan 11, 2024. The company reported -€0.076 earnings per share for the quarter, beating the consensus estimate of -€0.114 by €0.038.
Is Oramed Pharmaceuticals overvalued?
According to Wall Street analysts Oramed Pharmaceuticals’s price is currently Overvalued.
Does Oramed Pharmaceuticals pay dividends?
Oramed Pharmaceuticals does not currently pay dividends.
What is Oramed Pharmaceuticals’s EPS estimate?
Oramed Pharmaceuticals’s EPS estimate is <€0.01.
How many shares outstanding does Oramed Pharmaceuticals have?
Oramed Pharmaceuticals has 40,312,070 shares outstanding.
What happened to Oramed Pharmaceuticals’s price movement after its last earnings report?
Oramed Pharmaceuticals reported an EPS of -€0.076 in its last earnings report, beating expectations of -€0.114. Following the earnings report the stock price went down -1.234%.
Which hedge fund is a major shareholder of Oramed Pharmaceuticals?
Currently, no hedge funds are holding shares in DE:OJU1
---
Oramed Pharm Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
8.33%
12-Months-Change
Fundamentals
Return on Equity
2.92%
Trailing 12-Months
Asset Growth
-28.50%
Trailing 12-Months
Company Description
Oramed Pharmaceuticals
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.
---
OJU1 Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Oramed Pharm
―
TG Therapeutics
―
ESSA Pharma
―
Eloxx Pharmaceuticals
―
Moleculin Biotech
―
---